Literature DB >> 10713716

c-Abl: activation and nuclear targets.

Y Shaul1.   

Abstract

The c-Abl tyrosine kinase and its transforming variants have been implicated in tumorigenesis and in many important cellular processes. c-Abl is localized in the nucleus and the cytoplasm, where it plays distinct roles. The effects of c-Abl are mediated by multiple protein-protein and protein-DNA interactions and its tyrosine kinase domain. At the biochemical level, the mechanism of c-Abl kinase activation and the identification of its target proteins and cellular machineries have in part been solved. However, the phenotypic outcomes of these molecular events remained in large elusive. c-Abl has been shown to regulate the cell cycle and to induce under certain conditions cell growth arrest and apoptosis. In this respect the interaction of c-Abl with p53 and p73 has attracted particular attention. Recent findings have implicated c-Abl in an ionizing irradiation signaling pathway that elicits apoptosis. In this pathway p73 is an important immediate downstream effector. Here I review the current knowledge about these nuclear processes in which c-Abl is engaged and discuss some of their possible implications on cell physiology. Cell Death and Differentiation (2000) 7, 10 - 16.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713716     DOI: 10.1038/sj.cdd.4400626

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  38 in total

1.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2.

Authors:  Rom Keshet; Zina Bryansker Kraitshtein; Matan Shanzer; Julia Adler; Nina Reuven; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

3.  The c-Abl expression in uterine epithelium during the mouse estrus cycle.

Authors:  A Yaba Ucar; U A Kayisli; N Demir
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

4.  A positive role for c-Abl in Atm and Atr activation in DNA damage response.

Authors:  X Wang; L Zeng; J Wang; J F L Chau; K P Lai; D Jia; A Poonepalli; M P Hande; H Liu; G He; L He; B Li
Journal:  Cell Death Differ       Date:  2010-08-27       Impact factor: 15.828

5.  The Abelson tyrosine kinase (c-Abl) expression on the mouse uterus and placenta during gestational period.

Authors:  Aylin Yaba; Umit Ali Kayisli; Joshua Johnson; Ramazan Demir; Necdet Demir
Journal:  J Mol Histol       Date:  2011-01-20       Impact factor: 2.611

Review 6.  The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells.

Authors:  Tressa M Allington; William P Schiemann
Journal:  Cells Tissues Organs       Date:  2010-11-03       Impact factor: 2.481

7.  A Split-Abl Kinase for Direct Activation in Cells.

Authors:  Juan E Diaz; Charles W Morgan; Catherine E Minogue; Alexander S Hebert; Joshua J Coon; James A Wells
Journal:  Cell Chem Biol       Date:  2017-09-14       Impact factor: 8.116

8.  Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl.

Authors:  Hidehiko Kawai; Linghu Nie; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases.

Authors:  Kathryn E Tifft; Katherine A Bradbury; Katherine L Wilson
Journal:  J Cell Sci       Date:  2009-09-29       Impact factor: 5.285

10.  The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains.

Authors:  Robert Tamayev; Dawang Zhou; Luciano D'Adamio
Journal:  Mol Neurodegener       Date:  2009-07-14       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.